{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:08:38Z","timestamp":1791724118117,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","award":["PNURSP2022R39"],"award-info":[{"award-number":["PNURSP2022R39"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","award":["RSP-2021\/97"],"award-info":[{"award-number":["RSP-2021\/97"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013414","name":"Conseil R\u00e9gional des Pays de la Loire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["2020 07132"],"award-info":[{"award-number":["2020 07132"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.biopha.2022.113673","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T09:35:53Z","timestamp":1662543353000},"page":"113673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Investigation of the impact of rosuvastatin and telmisartan in doxorubicin-induced acute cardiotoxicity"],"prefix":"10.1016","volume":"154","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afrah Fahad","family":"Alkhuriji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa Abdullah I.","family":"Al-Megrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engy","family":"Elekhnawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa A.","family":"Negm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"De Waard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2022.113673_bib1","first-page":"1","article-title":"Epigenetic targeting drugs potentiate chemotherapeutic effects in solid tumor therapy","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.113673_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.905828","article-title":"Combination of Panax ginseng CA Mey and febuxostat boasted cardioprotective effects against doxorubicin-induced acute cardiotoxicity in rats","volume":"13","author":"Al-Kuraishy","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113673_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117173","article-title":"The role of melatonin on doxorubicin-induced cardiotoxicity: a systematic review","volume":"241","author":"Najafi","year":"2020","journal-title":"Life Sci."},{"issue":"15","key":"10.1016\/j.biopha.2022.113673_bib4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/ars.2020.8016","article-title":"Cardiac damage in anthracyclines therapy: focus on oxidative stress and inflammation","volume":"32","author":"Rocca","year":"2020","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.biopha.2022.113673_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/med.21280","article-title":"Doxorubicin\u2010induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy","volume":"34","author":"Carvalho","year":"2014","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2022.113673_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/prd.12315","article-title":"Periodontal therapeutics: current host\u2010modulation agents and future directions","volume":"82","author":"Golub","year":"2020","journal-title":"Periodontology 2000"},{"issue":"8","key":"10.1016\/j.biopha.2022.113673_bib7","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00210-021-02119-w","article-title":"Doxorubicin and doxorubicin-loaded nanoliposome induce senescence by enhancing oxidative stress, hepatotoxicity, and in vivo genotoxicity in male Wistar rats","volume":"394","author":"Shokrzadeh","year":"2021","journal-title":"Naunyn Schmiede's Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113673_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.trsl.2019.03.001","article-title":"Cardiac fibrosis: potential therapeutic targets","volume":"209","author":"Park","year":"2019","journal-title":"Transl. Res."},{"issue":"7","key":"10.1016\/j.biopha.2022.113673_bib9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00210-021-02081-7","article-title":"Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats","volume":"394","author":"Mounier","year":"2021","journal-title":"Naunyn Schmiede's. Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113673_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2022.113673_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/FJC.0000000000000646","article-title":"Atorvastatin improves doxorubicin-induced cardiac dysfunction by modulating Hsp70, Akt, and MAPK signaling pathways","volume":"73","author":"Gao","year":"2019","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113673_bib12","first-page":"1","article-title":"Statins for cardiac and vascular protection during and after cancer therapy","author":"Heiston","year":"2022","journal-title":"Curr. Oncol. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2022.113673_bib13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/phar.2681","article-title":"Statin\u2010associated muscle symptoms\u2014a review: Individualizing the approach to optimize care","volume":"42","author":"Wiggins","year":"2022","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"issue":"1","key":"10.1016\/j.biopha.2022.113673_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.418","article-title":"in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers","volume":"8e2564","author":"Henninger","year":"2018","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.biopha.2022.113673_bib15","first-page":"1395","article-title":"Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and\/or trastuzumab: a systematic review and meta-analysis","volume":"32","author":"Obasi","year":"2021","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.biopha.2022.113673_bib16","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/j.2040-4603.2019.tb00082.x","article-title":"Doxorubicin-induced cardiomyopathy in children","volume":"9","author":"Mancilla","year":"2019","journal-title":"Compr. Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2022.113673_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/1440-1681.12943","article-title":"Activation of voltage-gated sodium current and inhibition of erg-mediated potassium current caused by telmisartan, an antagonist of angiotensin II type-1 receptor, in HL-1 atrial cardiomyocytes","volume":"45","author":"Chang","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113673_bib18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3390\/biom11070979","article-title":"Receptor interactions of angiotensin II and angiotensin receptor blockers\u2014relevance to COVID-19","volume":"11","author":"Moore","year":"2021","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.biopha.2022.113673_bib19","first-page":"382","article-title":"Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats","volume":"60","author":"Iqbal","year":"2008","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2022.113673_bib20","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3390\/molecules23051184","article-title":"The cardioprotective effect of metformin in doxorubicin-induced cardiotoxicity: the role of autophagy","volume":"23","author":"Zilinyi","year":"2018","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.biopha.2022.113673_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.phrs.2009.05.007","article-title":"Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity","volume":"60","author":"Ibrahim","year":"2009","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.113673_bib22","doi-asserted-by":"crossref","first-page":"A. 4B. 1","DOI":"10.1002\/0471141755.pha04bs59","article-title":"Guidelines for the care and use of laboratory animals in biomedical research","volume":"59","author":"Jones\u2010Bolin","year":"2012","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113673_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ijc.27991","article-title":"Clinical use of p-proteasome in discriminating metastatic melanoma patients: Comparative study with LDH, MIA and S100B protein","volume":"133","author":"Henry","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2022.113673_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"4\u20135","key":"10.1016\/j.biopha.2022.113673_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clinbiochem.2014.10.013","article-title":"Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity","volume":"48","author":"Christenson","year":"2015","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2022.113673_bib26","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s10741-020-09948-6","article-title":"Research progress of biomarkers in early detection of chemotherapy-induced cardiotoxicity","volume":"26","author":"Gai","year":"2021","journal-title":"Heart Fail. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2022.113673_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-017-0184-z","article-title":"Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis","volume":"19","author":"Shaker","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"12","key":"10.1016\/j.biopha.2022.113673_bib28","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s12012-021-09694-7","article-title":"Dose-dependent cardioprotective effect of hemin in doxorubicin-induced cardiotoxicity via Nrf-2\/HO-1 and TLR-5\/NF-\u03baB\/TNF-\u03b1 signaling pathways","volume":"21","author":"Refaie","year":"2021","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.biopha.2022.113673_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111679","article-title":"Comparative study on beneficial effects of vitamins B and D in attenuating doxorubicin induced cardiotoxicity in rats: emphasis on calcium homeostasis","volume":"140","author":"Awad","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113673_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111732","article-title":"Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting TLR4\/NF-\u03baB and Wnt\/\u03b2-catenin pathways","author":"El-Ela","year":"2022","journal-title":"Nutrition"},{"issue":"7","key":"10.1016\/j.biopha.2022.113673_bib31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12012-021-09644-3","article-title":"Chia seed oil ameliorates doxorubicin-induced cardiotoxicity in female wistar rats: an electrocardiographic, biochemical and histopathological approach","volume":"21","author":"Ahmed","year":"2021","journal-title":"Cardiovasc. Toxicol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113673_bib32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00059-020-04957-5","article-title":"Echocardiography and biomarkers for the diagnosis of cardiotoxicity","volume":"45","author":"Berliner","year":"2020","journal-title":"Herz"},{"key":"10.1016\/j.biopha.2022.113673_bib33","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3389\/fphar.2021.670479","article-title":"Analysis of models of doxorubicin-induced cardiomyopathy in rats and mice. A modern view from the perspective of the pathophysiologist and the clinician","volume":"12","author":"Podyacheva","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113673_bib34","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/1078-0432.CCR-17-2046","article-title":"Extracellular vesicles released by cardiomyocytes in a doxorubicin-induced cardiac injury mouse model contain protein biomarkers of early cardiac InjuryEVs contain a sensitive protein barcode detectable in blood","volume":"24","author":"Yarana","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2022.113673_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/ph15050549","article-title":"Mechanistic insights on the in vitro antibacterial activity and in vivo hepatoprotective effects of salvinia auriculata aubl against methotrexate-induced liver injury","volume":"15","author":"Attallah","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2022.113673_bib36","article-title":"Combination of vitamin C and curcumin safeguards against methotrexate-induced acute liver injury in mice by synergistic antioxidant effects","volume":"9","author":"Khudhair","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2022.113673_bib37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.phrs.2018.01.009","article-title":"Metabolic syndrome, autoimmunity and rheumatic diseases","volume":"133","author":"Medina","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2022.113673_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cotox.2018.01.005","article-title":"Retinoic acid-related orphan receptor \u03b3 (ROR\u03b3): connecting sterol metabolism to regulation of the immune system and autoimmune disease","volume":"8","author":"Jetten","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.biopha.2022.113673_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jtemb.2018.01.016","article-title":"Nanoceria ameliorates doxorubicin induced cardiotoxicity: possible mitigation via reduction of oxidative stress and inflammation","volume":"47","author":"Sangomla","year":"2018","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"24","key":"10.1016\/j.biopha.2022.113673_bib40","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1039\/D1TB00551K","article-title":"The role of iron in doxorubicin-induced cardiotoxicity: recent advances and implication for drug delivery","volume":"9","author":"Qin","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"5","key":"10.1016\/j.biopha.2022.113673_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165665","article-title":"Protective effect of curcumin nanoparticles against cardiotoxicity induced by doxorubicin in rat","volume":"1866","author":"Mohammed","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2022.113673_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.biopha.2022.113673_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/met.2019.0073","article-title":"Novel invasive and noninvasive cardiac-specific biomarkers in obesity and cardiovascular diseases","volume":"18","author":"Parsanathan","year":"2020","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"2","key":"10.1016\/j.biopha.2022.113673_bib44","doi-asserted-by":"crossref","DOI":"10.29409\/ijcmg.v7i2.138","article-title":"Ameliorating the anticancer drug\u201d Adriamycin\u201d acute cardiotoxicity by rosuvastatin and telmisartan in rats","volume":"7","author":"Ahmed","year":"2014","journal-title":"Iraqi J. Cancer Med. Genet."},{"key":"10.1016\/j.biopha.2022.113673_bib45","first-page":"9","article-title":"Pre-treatment with lisinopril and\/or lovastatin lessen and ameliorate cardiotoxicity of doxorubicin in rats","volume":"5","author":"Alkuraishy","year":"2015","journal-title":"Apoptosis"},{"issue":"6","key":"10.1016\/j.biopha.2022.113673_bib46","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3109\/15376516.2012.678406","article-title":"Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats","volume":"22","author":"Kim","year":"2012","journal-title":"Toxicol. Mech. Methods"},{"issue":"2","key":"10.1016\/j.biopha.2022.113673_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijcard.2010.04.008","article-title":"Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy","volume":"150","author":"Sharma","year":"2011","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113673_bib48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4274\/tjps.galenos.2021.70745","article-title":"Ameliorative potential of rosuvastatin on doxorubicin-induced cardiotoxicity by modulating oxidative damage in rats","volume":"19","author":"Rajangam","year":"2022","journal-title":"Turk. J. Pharm. Sci."},{"issue":"23","key":"10.1016\/j.biopha.2022.113673_bib49","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1177\/15353702211035058","article-title":"Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction","volume":"246","author":"Chang","year":"2021","journal-title":"Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2022.113673_bib50","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40005-022-00567-x","article-title":"The combined effects of telmisartan and ramipril on hypertension and cardiovascular injury","volume":"52","author":"Lee","year":"2022","journal-title":"J. Pharm. Investig."},{"issue":"7","key":"10.1016\/j.biopha.2022.113673_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22785","article-title":"Cardioprotective effects of Azilsartan compared with that of telmisartan on an in vivo model of myocardial ischemia-reperfusion injury","volume":"35","author":"Garg","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113673_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2261-12-63","article-title":"Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response","volume":"12","author":"Hadi","year":"2012","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.biopha.2022.113673_bib53","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2147\/DMSO.S265399","article-title":"Anti-diabetic effect of telmisartan through its partial PPAR\u03b3-agonistic activity","volume":"13","author":"Ayza","year":"2020","journal-title":"Diabetes, Metab. Syndr. Obes. Targets Ther."},{"issue":"2","key":"10.1016\/j.biopha.2022.113673_bib54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5455\/jcvs.2015321","article-title":"Significant attenuation and amelioration effects of labetalol in doxorubicininduced cardiotoxicity: an animal model study","volume":"3","author":"Al-Kuraishy","year":"2015","journal-title":"Cardiovasc. Surg."},{"key":"10.1016\/j.biopha.2022.113673_bib55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cbi.2019.05.017","article-title":"Protective effect of morin on doxorubicin-induced hepatorenal toxicity in rats","volume":"308","author":"Kuzu","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.biopha.2022.113673_bib56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/13813455.2019.1630652","article-title":"Dortbudak, Protective effects of gallic acid on doxorubicin-induced cardiotoxicity; an experimantal study","volume":"127","author":"Ekinci Akdemir","year":"2021","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2022.113673_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109784","article-title":"Irigenin treatment alleviates doxorubicin (DOX)-induced cardiotoxicity by suppressing apoptosis, inflammation and oxidative stress via the increase of miR-425","volume":"125","author":"Guo","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113673_bib58","doi-asserted-by":"crossref","unstructured":"N.D. Zeybek, N.E. Gulcelik, F.F. Kaymaz, C. Sarisozen, I. Vural, E. Bodur, H. Canpinar, A. Usman, E. Asan, Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells, (2011).","DOI":"10.1530\/JOE-10-0411"},{"issue":"3","key":"10.1016\/j.biopha.2022.113673_bib59","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.eururo.2010.05.024","article-title":"Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer","volume":"58","author":"Wang","year":"2010","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.biopha.2022.113673_bib60","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/cpr.12018","article-title":"Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-\u03baB in lung cancer and in normal pulmonary tissues","volume":"46","author":"Falcone","year":"2013","journal-title":"Cell Prolif."},{"issue":"5","key":"10.1016\/j.biopha.2022.113673_bib61","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.3892\/or.2017.5977","article-title":"Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest","volume":"38","author":"Oura","year":"2017","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2022.113673_bib62","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.3390\/molecules19032862","article-title":"Telmisartan exerts anti-tumor effects by activating peroxisome proliferator-activated receptor-\u03b3 in human lung adenocarcinoma A549 cells","volume":"19","author":"Li","year":"2014","journal-title":"Molecules"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222010629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222010629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:44:40Z","timestamp":1791661480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222010629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":62,"alternative-id":["S0753332222010629"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113673","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the impact of rosuvastatin and telmisartan in doxorubicin-induced acute cardiotoxicity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113673"}}